View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

Tenders Direct Team photo
Reviewed By
Our Specialist Team

Notice Summary

Title:
United Kingdom-Bracknell: Compunded Infliximab for Intravenous Infusion
Document Ref:
373563-2020
Document Type:
Contract Notice - Restricted Procedure
Published By:
Berkshire Healthcare NHS Foundation Trust
Date Published:
07 August 2020
Deadline Date:
02 September 2020
Document Source:
Framework/DPS:
Yes
Alert Profile:
Labels:
Tenders Direct Team photo
Reviewed By
Our Specialist Team

Notice Abstract

Provision of compounded infliximab to: Trusts who are members of:— Thames Valley and Wessex Pharmacy Procurement Service,— NHS Commercial Solutions,— East of England NHS Collaborative Procurement Hub,— NHS London Procurement Partnership.Full details of all Trusts involved can be found in the SSQ and ITT documents. These can be found at: https://www.nhssourcing.co.uk/bhft/web/login.shtmlThe requirement will be split into five lots as follows:Lot 1: Inflectra,Lot 2: Remicade,Lot 3: Remsima,Lot 4: Flixabi, andLot 5: Zessly.This will be a ranked framework with a maximum of five suppliers per lot.

Notice Details

Contract notice

Directive 2014/24/EU - Public Sector Directive

Directive 2014/24/EU

Section I: Contracting authority

I.1) Name and addresses

Berkshire Healthcare NHS Foundation Trust

Fitzwilliam House, Skimped Hill Lane

Bracknell

RG12 1BQ

UK

Telephone: +44 1344415765

E-mail: tim.shannon@berkshire.nhs.uk

NUTS: UK

Internet address(es)

Main address: https://www.berkshirehealthcare.nhs.uk/

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://www.nhssourcing.co.uk/bhft/web/login.shtml


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://www.nhssourcing.co.uk/bhft/web/login.shtml


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Compunded Infliximab for Intravenous Infusion

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Provision of compounded infliximab to: Trusts who are members of:

— Thames Valley and Wessex Pharmacy Procurement Service,

— NHS Commercial Solutions,

— East of England NHS Collaborative Procurement Hub,

— NHS London Procurement Partnership.

Full details of all Trusts involved can be found in the SSQ and ITT documents. These can be found at: https://www.nhssourcing.co.uk/bhft/web/login.shtml

The requirement will be split into five lots as follows:

Lot 1: Inflectra,

Lot 2: Remicade,

Lot 3: Remsima,

Lot 4: Flixabi, and

Lot 5: Zessly.

This will be a ranked framework with a maximum of five suppliers per lot.

II.1.5) Estimated total value

Value excluding VAT: 5 000 000.00 GBP

II.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

II.2) Description

Lot No: 1

II.2.1) Title

Inflectra

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Inflectra.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

Two options for 12-month extensions.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

Remicade

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Remicade.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in working days: 24

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

Two options for 12-month extensions.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 3

II.2.1) Title

Remsima

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Remsima.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

Two options for 12-month extensions.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 4

II.2.1) Title

Flixabi

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Flizabi.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

Two options for 12-month extensions.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 5

II.2.1) Title

Zessly

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Zessly.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

Two options for 12-month extensions.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:

TO download a SSQ, register your company on the eSourcing portal (this is only required once):

— browse to the ESourcing Portal: https://www.nhssourcing.co.uk/bhft/web/login.shtml and click the link to register;

— accept the terms and conditions and click ‘continue’;

— enter your correct business and user details;

— note the username you chose and click ‘save’ when complete;

— you will shortly receive an email with your unique password (please keep secure).

Login to the portal with the username/password:

— click the ‘PQQ/ITTs open to all suppliers’ link (these are Pre-Qualification Questionnaires or tenders open to any registered suppliers);

— click on the relevant PQQ/ITT to access the content;

— click the ‘Express Interest’ button in the ‘Actions’ box on the left-hand side of the page. This will move the PQQ into your My PQQ/My ITTs page (this is a secure area reserved for your projects only);

— you can now access any of the attachments by clicking the ‘Settings and Buyer Attachment’ in the ‘Actions’ box.

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents

III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Restricted procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement with several operators.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 02/09/2020

Local time: 10:00

IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates

Date: 29/09/2020

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.4) Procedures for review

VI.4.1) Review body

The High Court of England and Wales

The Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

VI.5) Date of dispatch of this notice

03/08/2020

Current Notes